CTRI/2018/01/011065已完成4 期
ARDA (Automated Detection Algorithm) assisted read study protocol - Aravind Diabetic Retinopathy Evaluation Software (ADRES) related study
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Google Inc
- 入组人数
- 1,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Recruitment of patients from the diabetic clinics which use ADRES (Aravind Diabetic Retinopathy Evaluation Software) grading system. An eligible patient must have a diagnosis of diabetes mellitus.
排除标准
- •Non-diabetic patients
研究者
相似试验
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06762340[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT04945941[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06733259[Redacted]
已完成
不适用
Clinical Investigation (Beta) of a New Developed Prosthetic KneeNCT06748729Össur Iceland ehf11
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06422065[Redacted]